![]() |
|
|
Vol. 61, Issue 6, 1366-1376, June 2002
Department of Chemistry, Analytical Chemistry, University of
Konstanz, Konstanz, Germany (C.B., T.D., M.P.); and Byk Gulden Lomberg
GmbH, Konstanz, Germany (R.B., K.K., V.F., W.-R.U., S.H., W.I., V.G.)
Human P-glycoprotein (P-gp), an integral membrane transport protein, is
responsible for the efflux of various drugs, including cytostatics from
cancer cells leading to multidrug resistance. P-gp is composed of two
homologous half domains, each carrying one nucleotide binding site. The
drug extrusion is ATP-dependent and can be inhibited by
chemosensitizers, such as the dihydropyridine derivative
dexniguldipine-HCl, through direct interaction with P-gp. To evaluate
the mechanism(s) of chemosensitization and identify the binding sites
of dexniguldipine-HCl, a tritium-labeled azido analog of
dexniguldipine, [3H]B9209-005, was used as a
photoaffinity probe. Using the multidrug resistant T-lymphoblastoid
cell line CCRF-ADR5000, two proteins were specifically labeled in
membranes by [3H]B9209-005. These proteins were
identified by immunoprecipitation such as P-gp and its N-terminal
fragment. The membranes were solubilized and the labeled P-gp proteins
first isolated by lectin-chromatography and then digested with trypsin.
SDS-polyacrylamide gel electrophoresisanalysis of the digest revealed a
major radioactive 7-kDa fragment. The tryptic fragments were separated
by high-performance liquid chromatography and analyzed by
matrix-assisted laser desorption/ionization mass spectrometry
(MALDI-MS). The MS results, corroborated by MALDI-MS of peptides after
one step of Edman analysis, identified the radioactive 7-kDa band as
the dexniguldipine-bound, tryptic P-gp peptide, 468-527. This sequence
region is flanked by the Walker motifs A and B of the N-terminal
ATP-binding cassette suggesting direct interaction of the
chemosensitizer with the nucleotide binding site is involved in the
mechanism of chemosensitization.
This article has been cited by other articles:
![]() |
L. Q. Al-Mawsawi, V. Fikkert, R. Dayam, M. Witvrouw, T. R. Burke Jr., C. H. Borchers, and N. Neamati From the Cover: Discovery of a small-molecule HIV-1 integrase inhibitor-binding site PNAS, June 27, 2006; 103(26): 10080 - 10085. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pedemonte, T. Diena, E. Caci, E. Nieddu, M. Mazzei, R. Ravazzolo, O. Zegarra-Moran, and L. J. V. Galietta Antihypertensive 1,4-Dihydropyridines as Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating Defect Caused by Cystic Fibrosis Mutations Mol. Pharmacol., December 1, 2005; 68(6): 1736 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-f. Zhou, X. Yang, Q. Wang, R. A. Coburn, and M. E. Morris EFFECTS OF DIHYDROPYRIDINES AND PYRIDINES ON MULTIDRUG RESISTANCE MEDIATED BY BREAST CANCER RESISTANCE PROTEIN: IN VITRO AND IN VIVO STUDIES Drug Metab. Dispos., August 1, 2005; 33(8): 1220 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Ecker, K. Pleban, S. Kopp, E. Csaszar, G. J. Poelarends, M. Putman, D. Kaiser, W. N. Konings, and P. Chiba A Three-Dimensional Model for the Substrate Binding Domain of the Multidrug ATP Binding Cassette Transporter LmrA Mol. Pharmacol., November 1, 2004; 66(5): 1169 - 1179. [Abstract] [Full Text] [PDF] |
||||